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An estimated 795,000 Americans experience stroke every year, and stroke incidence is expected to increase as the population ages. 1, 2 Although classically considered to have increased stiffness resulting solely from the velocity-dependent stretch reflex, numerous investigations have identified increased nonreflex passive joint stiffness in subjects with chronic stroke. 3Y16 These musculoskeletal manifestations, including reduced range of motion and increased resistance to passive movement, have a multitude of functional implications, including alterations in gait. 1, 9, 14, 17 Fortunately, accurately directed therapies to improve passive joint stiffness can improve functional outcomes. 14, 18 Thus, it is necessary to accurately recognize and diagnose nonreflex passive stiffness due to chronic stroke to offer targeted treatments as opposed to typical pharmacologic spasticity interventions which often aim to blunt neuromuscular activation. 3, 5, 19 Unfortunately, accurate analysis of passive joint stiffness generally requires complex systems to monitor whole-joint torque and surface electromyography (EMG), which are impractical for routine clinical use. As a result, clinical measures are generally limited to evaluating spasticity using the 5-point Modified Ashworth Scale (MAS), which is easy to use and requires no equipment 3, 5, 20 but does not distinguish between reflex-and nonYreflex-mediated stiffness. 10, 21, 22 Furthermore, the MAS is qualitative and subjective, shows poor validity especially when evaluating multiple muscle groups, 3,23Y25 and fails to distinguish the ongoing biomechanical changes present in chronic stroke. 26Y28 Although elevated passive joint stiffness is well documented after stroke, 4,6Y16,29 these assessments tend to evaluate whole-joint propertiesVincluding the capsule, ligaments, and all associated muscles and tendonsVmaking it challenging to develop and implement targeted therapies to improve function. Elevated passive joint stiffness after stroke has been shown to coincide with alterations in muscle architecture, including reduced fascicle length, pennation angle, and range of motion. 4, 6, 16, 30 Further investigations are needed to continue to evaluate local tissue properties and uncover the respective anatomic contributions to increased passive joint stiffness following stroke.
Shear wave elastography (SWE) is a quantitative ultrasound technique that is becoming increasingly popular in musculoskeletal applications. This noninvasive technique uses a single ultrasound transducer to first remotely induce shear waves and subsequently detect their propagation through tissue. 26,31Y33 The measured shear wave propagation velocity and known tissue density are then used to calculate shear modulus or the stiffness of the tissue. 34 SWE displays excellent reliability quantifying elevations in muscle stiffness with increased passive stretch throughout normal range of motion. 35, 36 For this reason, SWE shows promise for evaluating pathologic alterations in the stiffness of individual muscles and may provide valuable information for further characterizing the etiology of nonreflex passive stiffness associated with neuromuscular conditions.
The purpose of this pilot study was to evaluate the potential for SWE to measure passive biceps brachii muscle stiffness as a musculoskeletal manifestation of chronic stroke. This study sought to evaluate the relationship between biceps brachii stiffness as measured by SWE and whole-joint resistance as measured by torque during passive extension. It was hypothesized that SWE would be able to detect muscular sequelae of chronic stroke, presenting as alterations in stiffness in the static elbow and during passive extension.
METHODS Subjects
Nine subjects (seven men) with chronic stroke and four healthy controls (two men) participated in this study. The mean ages for the stroke and control groups were 58.3 yrs (range, 41Y79 yrs) and 56 yrs (range, 42Y70 yrs), respectively. A t test found no significant difference between mean ages for the two study groups (P = 0.77). Potential participants were recruited as a convenience sample from established patients in the Division of Brain Rehabilitation at Mayo Clinic. Inclusion criteria for the stroke group were 1) more than 3 mos after stroke causing spastic hemiparesis; 2) 18Y80 yrs old; 3) able to sit independently, provide written informed consent, and follow basic verbal commands; and 4) body mass index less than 30 kg/m 2 . Exclusion criteria included 1) abnormality of muscle tone unrelated to stroke; 2) limited passive range of motion at the elbow; 3) unstable cardiopulmonary condition; or 4) treatment with antispasticity medications or injections within the previous 6 mos. Inclusion and exclusion criteria were evaluated based on self-report. Control subjects were included if they fell within the same body mass index and age limitations and excluded if they had a history of stroke, arm or hand injury, or muscle tone abnormalities. The mean time since injury for the stroke group was 2.9 yrs (range, 10 mos to 7 yrs). Informed consent was obtained and all study procedures were approved by the institutional review board at Mayo Clinic.
Clinical Evaluation
Before biomechanical and ultrasound testing, an experienced, licensed, neuromuscular occupational therapist evaluated upper limb function and spasticity for all subjects with stroke using the Fugl-Meyer (F-M) assessment 1 and the MAS. 3, 5 The same occupational therapist performed all clinical evaluations to avoid interrater variation. The F-M assessment provides numerical evaluation of motor function, sensation, motion, and pain and is a reliable, valid measure of motor function for patients with chronic stroke. 1, 17 The MAS is the most commonly used clinical measure of spasticity and is easy to use largely because it requires no equipment. 18 The clinician moves the patient"s limb through passive range of motion and rates the resistance from 0 (no spasticity) to 4 (joint is rigid). 3, 5 
Experimental Setup
Simultaneous SWE and biomechanical testing were conducted on all subjects using a Verasonics ultrasound imaging system (Verasonics Inc, Kirkland, WA; Verasonics products do not have Food and Drug Administration clearance and are therefore to be used only for research) with an L7-4 linear array transducer (Philips Healthcare, Andover, MA) and a HUMAC2009 NORM dynamometer (Computer Sports Medicine Inc., Stoughton, MA), as indicated in Figure 1 . The dynamometer has a reported torque and position accuracy of 0.5% and T1/4 degree.
Both right and left upper limbs were tested for all subjects. To prevent fatigue and reduce conditioning effects from the previous clinical evaluation in the stroke group, the side ipsilateral to the lesioned hemisphere was tested first. Testing order was assigned randomly for the control group. All subjects were encouraged to relax as much as possible during the testing sessions.
Surface EMG was used to monitor muscle activity and ensure relaxation of the biceps brachii and triceps brachii muscles throughout all trials. Electrodes were placed over the muscle bellies of the long head of the biceps brachii and the lateral head of the triceps brachii bilaterally. The EMG electrodes were placed medially over the biceps to provide sufficient area over the anterior surface of the arm for the ultrasound transducer, and proper placement and signal quality with voluntary muscle contraction against manual resistance were confirmed. EMG signals were collected and monitored at 2400 Hz using the MA-300 (Motion Lab Systems, Baton Rouge, LA) throughout testing.
Biomechanical Evaluation
Subjects sat comfortably with their upper body securely strapped to the backrest, the nontesting arm resting in their lap and the testing arm abducted 5Y10 degrees at their side. After adjusting the dynamometer to ensure that the axis of rotation matched that of the subject"s elbow, the forearm was fixed to the dynamometer using a custom attachment fixture. The fixture firmly held the wrist in a neutral position while preserving a relaxed hand and forearm posture to ensure passive movements for the duration of the study.
The passive range of motion of each subject was initially evaluated to ensure that they could successfully and painlessly complete the study procedures. This process also served to familiarize the subject with the experimental setup and testing procedures. The dynamometer rotated each subject"s arm from 80 degrees extension to 150 degrees extension (180 degrees = full extension). To facilitate subject relaxation, testing was always in the same order: 5, 20, and 40 degrees/sec. Three trials of each Muscle Stiffness in Stroke rotation velocity per side were conducted, each separated by a 2-min rest. The value 5 degrees/sec was selected as the lowest velocity as it has been described to be slow enough to not elicit a spastic reflex response and thus would be representative of only the passive resistance to stretch. 20 The dynamometer returned the elbow to 80 degrees extension after each trial, where it was held until the next trial began. After all three trials were completed, the dynamometer and attachment fixture was adjusted to evaluate the contralateral side using the same procedure. The dynamometer recorded position, velocity, and torque at 100 Hz for all trials.
Torque data for gravity were corrected and the effects of inertial stiffness during the acceleration and deceleration phases of the dynamometer motion were eliminated by considering only the constant-velocity regions of the elbow extension movement. Torque values were selected at the time points corresponding to each SWE measurement during all trials for direct comparison with the respective SWE stiffness.
SWE Evaluation
Using a custom-molded probe holder that securely fixed to the upper arm, the L7-4 linear-array ultrasound transducer was attached over the midsubstance of the long head of the biceps brachii muscle. The probe holder allowed the ultrasound transducer to maintain even contact with the skin surface coupled with transmission gel, while preserving minimal, continuous contact pressure. The ultrasound transducer was aligned with the long axis of the biceps, which has minimal pennation such that the muscle fibers align well with the shear wave propagation direction. 21, 22 Before elbow extension trials, baseline elastography maps of the biceps brachii were collected with the elbow static at 80 and 150 degrees. A new SWE technology called comb-push ultrasound shear elastography (CUSE) 23 was used to image the two-dimensional muscle elasticity over an approximately 160 mm 2 region of interest. Three measurements were acquired at the 80-and 150-degree elbow angles.
During the elbow extension trials, single, onedimensional SWE measurements were acquired, triggered by the position output signal of the dynamometer, at 85, 90, 95, 100, 110, 120, 130, 140, and 150 degrees. For each SWE measurement, the L7-4 transducer first transmitted a 400-Ksec push pulse with 4.09 MHz center frequency focused at 2 or 2.5 cm depth, depending on muscle thickness.
The same transducer then recorded shear wave motion generated by the acoustic radiation force 26 from the push pulse (0.4-Ksec detection pulses with 5 MHz center frequency; receiving at frame rate = 5.85 kHz for 81 frames). Because each acquisition took less than 20 msecs, the muscle could be treated as stationary during the SWE measurements, even at 40 degrees/sec rotation speed. Shear wave motion was recorded using a high frame rate technique 29 and was calculated from the image data based on one-dimensional autocorrelation. 30 Shear wave speed was measured using a time-of-flight method 2,33 and used for later analysis to calculate shear modulus, or stiffness.
To calculate shear wave motion from the image data, the motion data at the focal depth of the push beam and between 3.08 and 18.48 mm away from the push beam were selected. All shear wave speed measures were converted to shear moduli using the equation K = c s 2 Q, where K is shear modulus, c s is shear wave propagation velocity, and Q is density, which can be assumed to be 1000 kg/m 3 for all soft tissues. 26
Data Analysis
The muscular sequelae of chronic stroke are often inconsistent from day to day and hour to hour, so used intraclass correlation coefficients (ICCs) were used to evaluate the reliability of demonstrating alterations in material properties. As the authors sought to evaluate the reliability of repeated measures with the same tool, they used the ICC(1,1) model with their repeated SWE and CUSE values. Statistical Analysis Software version 9.3 (SAS Institute Inc, Cary, NC) was used to calculate the ICC(1,1) for SWE at three randomly selected angles during passive elbow extension (90, 110, and 140) and for static measures with CUSE at 80 and 150 degrees for both the stroke and control groups. Reliability was considered to be Bexcellent[ for ICC (1, 1) greater than or equal to 0.75; Bgood[ for ICC(1,1) between 0.60 and 0.74; Bfair[ between 0.40 and 0.59; and Bpoor[ below 0.40. 37 Regression statistical methods were used to examine the relationship between biceps brachii stiffness, as measured by SWE, and whole-joint resistance, as measured by torque during passive extension. All trials at each rotation velocity were evaluated using stiffness as the independent variable. A generalized linear model was used to run the regression, which accounts for repeated testing of each limb. Generalized estimating equations via the GENMOD procedure in Statistical Analysis Software were used to estimate the model parameters. Generalized estimating equations are designed to accurately estimate regression parameters from repeated-measures data sets and thus were well suited for this analysis. 14, 38 The GENMOD procedure, using the Brepeated[ statement, properly accounts for the repeated testing of this study but does not produce a typical coefficient of determination as a measure of how well the statistical model fit the data. For this reason, Eq. (1) was used to manually calculate R 2 :
where ŷ i is the values predicted by the GENMOD procedure, y j is the mean of all observations, and y i is the observations. 19, 39 
RESULTS

Clinical Evaluation
The results from the clinical evaluation for the stroke group are included in Table 1 . This study included subjects with a range of F-M impairment severities and was unable to appreciate clinical levels of spasticity in several subjects using the MAS. Subjects S1 and S9 had the greatest MAS scores (3) on their contralateral (to the lesioned hemisphere) limbs, although S8 demonstrated clinical spasticity bilaterally (MAS scores of 2 on contralateral limb, 1 on ipsilateral limb). S8 also had the lowest motor and sensation scores on the F-M Assessment (6/66 and 3/12, respectively, sensation data not shown) when compared with all subjects with stroke. S1 and S6 showed similar levels of motor impairment, with scores of 16/66 and 20/66, respectively, although S6 did not show signs of clinical spasticity by the MAS. S3 and S4 similarly scored 0 on the MAS, but unlike S6 were among the highest scoring subjects on the motor subsection of the F-M (61/66 and 55/66, respectively). Little impairment was detected in passive joint motion and no joint pain was recorded in any subject. No clear association was found between stroke mechanism, location, or hemisphere and MAS or F-M assessment scores. With the exception of subject S1, with increasing time after stroke, increased spasticity and motor impairments were detected using the clinical evaluation measures.
SWE Evaluation
Surface EMG confirmed that the biceps brachii remained inactive throughout all testing. A sample set of representative baseline static elastography maps at 80 and 150 degrees is included in Figure 2 , along with median stiffness (shear modulus) from each map. Figures 2A and B demonstrate the increased stiffness seen in controls from flexed to extended elbow position, respectively. Figures 2CYF illustrate the marked increase in biceps stiffness with an extended elbow for the contralateral limb of a subject with stroke. Mean stiffness data for all subjects are included in Figure 3 . The ICC(1,1) values for all CUSE stiffness data at both 80 and 150 degrees for all subjects ranged from 0.76 to 0.99, although 95% confidence intervals were largely unfavorable.
Sample sets of individual SWE values throughout the prescribed range of motion are shown in Figure 4 . Similar to the biomechanical evaluation, SWE data for stroke subjects showed increased variation as compared with controls. Passive biceps brachii stiffness tended to increase with increasing elbow angle for all study groups and all rotation speeds. One subject in particular, S1, had massive increases in passive muscle stiffness as elbow angle increased. This effect was quite pronounced even at the lowest rotation speed, 5 degrees/sec, well below the spastic threshold, implicating a significant component of nonYreflex-mediated muscle stiffness. Most of the ICC(1,1) values for the three preselected angles were considered excellent, ranging from 0.75 to 0.97; however, 95% confidence intervals continued to be unfavorable for nearly all conditions aside from the dominant side of controls, as seen in Table 2 .
Individual stiffness from SWE was compared with torque obtained at the same time points using generalized estimating equation. Several unique trends were observed within the stroke study group, all of which differed from that of the controls. The control group displayed minimal increases in torque during extension and correlated minor increases in biceps muscle stiffness, as indicated in Figure 5A (y = 17.394x + 7.898; R 2 = 0.103; P G 0.0001). For the stroke group, subject S1 showed very strong responses to stretch for both torque and muscle stiffness, as shown in Figure 5B (y = 36.856x + 18.197; R 2 = 0.829; P G 0.0001). Four other subjects with stroke also had a similar, although somewhat attenuated, relationship between torque and stiffness; however, their individual data are not included here. As shown in Figure 5C , several subjects with stroke displayed a very strong torque response coupled with minimal stiffness responses (y = 2.712x + 6.676; R 2 = 0.181; P = 0.0310). Trends among the remaining subjects with chronic stroke were weak and marked by highly clustered data, with only small changes in torque or stiffness, somewhat similar to controls.
DISCUSSION
SWE shows promise for enhancing the understanding and evaluation of skeletal muscle affected by chronic stroke, especially as these ultrasound techniques become more readily available. Several patterns of stiffness and torque responses to passive elbow extension were identified. The wide variability found between subjects further highlights the need for precise and individualized measures.
Approximately half of the subjects with stroke expressed increases in joint torque during elbow extension, as measured by dynamometer, coupled with comparable increases in muscle stiffness, assessed by SWE. As their arm was extended, an increase in torque was observed about the elbow joint, much like a typical muscle response to stretch. 3, 5, 40 Their response to stretch displays some amplification when compared with healthy controlsV perhaps a manifestation of the chronic muscular effects of stroke. It is reasonable to assume that this increase in whole-joint stiffness could be detected clinically by the MAS, but SWE is an initial step toward either identifying or eliminating local changes within the muscle belly as the root cause of such increased stiffness. Further work must identify techniques to detect the relative contributions of muscle, associated tendons, ligaments, or joint capsule to the increased joint stiffness seen following stroke. EMG has the potential to clarify this, but only if the altered stiffness is the direct result of muscle contraction. This study"s subjects showed minimal EMG activity throughout testing, and one had minimal activation even when asked to contract his or her biceps maximally. The elevated SWE measures indicate that the elevated joint torque is due, at least in part, to intrinsic biomechanical alterations within the muscle.
A second subgroup of the subjects with stroke in this study had a very different response to passive elbow extension: comparable increases in torque were not matched with appreciable elevations in biceps brachii stiffness. This indicates that the increased resistance to passive extension was a result of other structures associated with the joint. It remains unclear whether this increased torque was the result of joint contracture or perhaps the activation of muscles not evaluated by the ultrasound transducer. However, these results confirm what is clinically evident in patient populations with brainassociated neuromuscular pathologies: muscle responses to passive stretch are highly variable and will require a range of specialized measurement techniques to fully evaluate and guide treatment protocols aimed at improving function and independence. In this limited feasibility study alone, a range of impairment (as assessed by the F-M scale) that appeared entirely unrelated to Ashworth scores or EMG activity during stretch was found. Furthermore, MAS scores showed no relationship with any of the testing measures, including EMG, F-M, torque, or stiffnessVindicating a need to revise or supplement the current standard clinical evaluation tools. The Tardieu Scale may provide a more sensitive manual rating scale to distinguish between spasticity and contracture 41Y43 but remains a subjective and qualitative measure like the MAS.
Numerous studiesVusing techniques ranging from range of motion, resistance to passive joint motion, or myotonometryVhave similarly outlined elevated muscle or joint stiffness in individuals with stroke. Reduced fascicle length and pennation angle may be related to the elevation in whole-muscle stiffness seen in chronic stroke survivors. 4 Goe et al. found increases in resistance to passive motion about the ankle in the paretic limb of stroke survivors when compared with the nonparetic ankle and those of normal controls but failed to find similar changes in the upper limb. 7 Elevated passive muscle-tendon and joint stiffness are frequently seen at the ankle after stroke, 9, 44 often accompanied by variable changes in active stiffness, 9 further highlighting the need for creative and sensitive techniques that distinguishes them.
The 95% confidence intervals for the ICC(1,1) analyses were generally poor, aside from the slower extension velocities for the dominant arm of the control group. All control subjects were righthanded, and it is possible that the consistent material properties of the biceps brachii were due to training effects of the dominant hand. As EMG confirmed minimal muscle activity throughout testing, it seems likely that either weak actin-myosin crossbridges 45, 46 or noncontractile elements, such as titin, 47, 48 were responsible for inconsistent muscle stiffness. This was especially striking when comparing the two study groups: the relative efficiency of the dominant hand of controls, as compared with their less trained, less efficient nondominant hand, or both limbs of the stroke group. It is also interesting to note that muscle stiffness was inconsistent at greater elbow extension for all testing conditions, likely indicative of the increased relative contribution of noncontractile elements to muscle stiffness at longer as opposed to shorter muscle lengths. Future studies should continue to evaluate the relationship between muscle shear modulus, training, and biomechanical efficiency of movement at a local muscle level.
Study Limitations
This study had several limitations. Passive muscle stiffness was evaluated in subjects during the chronic phase after stroke. Future studies should attempt to capture the evolution of changes in muscle and joint stiffness longitudinally during all phases of recovery. In addition, multiple cycles of elbow extension were evaluated, possibly conditioning the biceps brachii or other structures associated with the elbow joint, resulting in attenuated torque measures during later trials. Care was taken to ensure adequate rest time between each trial and there were no appreciable changes noticed in the study measures. Although the transducer was securely fixed to the skin, the muscles underneath the skin may slide during elbow extension. Therefore, the SWE measurements may not target precisely the same anatomic location within the muscle throughout the extension process. However, the time-of-flight results showed that the shear wave propagated with a constant speed over a relatively long distance (920 mm), indicating that the biceps muscle properties are consistent near the midbelly. Therefore, the results should not be affected much by the sliding. Furthermore, previous research indicates that local SWE measures obtained at the midsubstance of skeletal muscle may be as meaningful as whole-muscle measures, 22,34 although changes throughout muscle tissue as a result of chronic stroke should also be investigated. Finally, EMG was used only to ensure muscle inactivity, not in an attempt to quantify muscle activation. Future studies evaluating spasticity or active stiffness may find benefit from obtaining time-synced EMG activity measured intramuscularly that is normalized to maximum contraction levels.
CONCLUSIONS
This work demonstrates the unique capabilities of using SWE to obtain quantitative, real-time measures of the material properties of dynamic skeletal muscles. In this study, SWE measures were strictly synchronized with the subjects" arm movements, highlighting its potential as an alternative or complement to EMG evaluation. Although only passive stiffness was evaluated during relatively slow velocities, the present investigation is a first step toward future studies, which can assess active, functional skeletal muscle during a range of activities for a variety of neuromuscular and musculoskeletal pathologies. Development and refinement of innovative, accessible, noninvasive techniques such as SWE may lead to a better understanding of what is occurring within the muscle and associated soft tissue elements, guiding therapies to reduce impairment-related functional limitations when brain function is altered by injury or disease.
